You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RMS

Showing 26 - 50 of 544
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Complementary Feeding Trial in Ikeja, Kaduna (A&T IYCF intervention)

Completed
  • Complementary Feeding
  • A&T IYCF intervention
  • Ikeja, Lagos, Nigeria
  • +1 more
Jan 13, 2021

Reduce Errors and Nursing Workload

Completed
  • Acute Kidney Injury
  • Kidney Injury
  • Clarity RMS Electronic Sensor
  • Pittsburgh, Pennsylvania
    UPMC Presbyterian Hosptial
May 6, 2021

Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 13, 2022

Suboptimally Controlled Participants Previously Taking

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Cullman, Alabama
  • +38 more
Jul 19, 2022

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Relapsing Forms of Multiple Sclerosis Trial in China, Japan (Diroximel fumarate)

Recruiting
  • Relapsing Forms of Multiple Sclerosis
  • Diroximel fumarate
  • Tianjin, China
  • +23 more
Jul 22, 2022

Rhabdomyosarcoma Trial in Sutton, Manchester (Irinotecan, Actinomycin D, Doxorubicin)

Recruiting
  • Rhabdomyosarcoma
  • Camperdown, Australia
  • +89 more
Jan 3, 2023

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Cullman, Alabama
  • +165 more
Jan 13, 2023

Coronary Artery Disease Trial in Bad Segeberg, Kempten (Magmaris)

Recruiting
  • Coronary Artery Disease
  • Magmaris
  • Bad Segeberg, Germany
  • +1 more
Dec 17, 2020

Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin

Completed
Has Results
  • Relapsed/Refractory Rhabdomyosarcoma
  • +2 more
  • Eribulin mesylate
  • Birmingham, Alabama
  • +40 more
Mar 18, 2022

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Suboptimally Controlled Participants Previously Taking Oral or

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Cullman, Alabama
  • +66 more
Nov 29, 2022

Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

Active, not recruiting
  • Relapsing Multiple Sclerorsis
  • Multiple Sclerosis, Primary Progressive
  • Palo Alto, California
  • +16 more
Jul 26, 2022

Multiple Sclerosis Trial in Worldwide (ofatumumab with PRF, ofatumumab with AI)

Completed
Has Results
  • Multiple Sclerosis
  • ofatumumab with PRF
  • ofatumumab with AI
  • Fullerton, California
  • +40 more
Oct 7, 2021

Rapid Mood Screener in Adult Unipolar Major Depressive Disorder

Not yet recruiting
  • Bipolar I Disorder
    • (no location specified)
    Jul 14, 2023

    Relapsing Multiple Sclerosis Trial in Worldwide (Remibrutinib, Teriflunomide)

    Recruiting
    • Relapsing Multiple Sclerosis
    • Hanford, California
    • +41 more
    Aug 5, 2022

    Relapsing Multiple Sclerosis Trial in United States (Fingolimod)

    Completed
    Has Results
    • Relapsing Multiple Sclerosis
    • Birmingham, Alabama
    • +65 more
    Oct 6, 2021

    Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old

    Active, not recruiting
    • Rhabdomyosarcoma
      • Bordeaux, France
      • +19 more
      Jul 19, 2022

      Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United

      Recruiting
      • Embryonal Rhabdomyosarcoma
      • +2 more
      • Birmingham, Alabama
      • +47 more
      Aug 17, 2022

      Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

      Not yet recruiting
      • Relapsing Multiple Sclerosis
      • No intervention
      • (no location specified)
      Nov 16, 2023

      Ocrelizumab and Ofatumumab Administration in Relapsing Multiple

      Completed
      • Relapsing Forms of Multiple Sclerosis
      • Lutherville, Maryland
      • +1 more
      Oct 19, 2022

      Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Saint Louis (Cladribine)

      Recruiting
      • Multiple Sclerosis
      • Multiple Sclerosis, Relapsing-Remitting
      • Saint Louis, Missouri
      • +4 more
      Jan 4, 2023

      Respiratory Monitoring System Safety and Performance Study

      Recruiting
      • Pulmonary Function Test
      • +4 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University Hospital
        Apr 2, 2023

        Relapsing Multiple Sclerosis (RMS) Trial in Worldwide (Ublituximab)

        Enrolling by invitation
        • Relapsing Multiple Sclerosis (RMS)
        • Ublituximab
        • Pasadena, California
        • +84 more
        Mar 22, 2022